Evaluation of safety and efficacy of azithromycin in lower respiratory tract infections (LRTI) 1996

P Adhikari, and B M Hegde, and P Pereira, and P Bhat, and N Chowta, and K V Ramesh, and T V Venkatadri, and M M Pai
Department of Medicine, Kasturba Medical College, Mangalore, Karnataka, India.

Azithromycin was given to 55 cases of lower respiratory tract infections in the doses of 500 mg on day 1, followed by 250 mg on days 2-5. It produced bacteriological cure in 70.8% patients and clinical cure or improvement in 69.09% of patients. 4.27% of patients had throat colonisation with new organisms, of which 9.09% needed a second antibiotic. The drug was well tolerated and minor side effects were noted. Gastrointestinal disturbances (16.36%) headache and giddiness (14.55%), rash (3.64%) were the noted side effects. Reduction of platelet count by 50% occurred in 12.29% of the cases compared to 0.2% reported earlier. But this thrombocytopenia was clinically not significant, as it did not cause any symptoms.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008297 Male Males
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017963 Azithromycin A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. Azadose,Azithromycin Dihydrate,Azithromycin Monohydrate,Azitrocin,Azythromycin,CP-62993,Goxal,Sumamed,Toraseptol,Ultreon,Vinzam,Zentavion,Zithromax,Zitromax,CP 62993,CP62993,Dihydrate, Azithromycin,Monohydrate, Azithromycin

Related Publications

P Adhikari, and B M Hegde, and P Pereira, and P Bhat, and N Chowta, and K V Ramesh, and T V Venkatadri, and M M Pai
February 1993, Journal of chemotherapy (Florence, Italy),
P Adhikari, and B M Hegde, and P Pereira, and P Bhat, and N Chowta, and K V Ramesh, and T V Venkatadri, and M M Pai
July 1994, International journal of antimicrobial agents,
P Adhikari, and B M Hegde, and P Pereira, and P Bhat, and N Chowta, and K V Ramesh, and T V Venkatadri, and M M Pai
October 2005, Expert opinion on pharmacotherapy,
P Adhikari, and B M Hegde, and P Pereira, and P Bhat, and N Chowta, and K V Ramesh, and T V Venkatadri, and M M Pai
January 1992, Scandinavian journal of infectious diseases. Supplementum,
P Adhikari, and B M Hegde, and P Pereira, and P Bhat, and N Chowta, and K V Ramesh, and T V Venkatadri, and M M Pai
August 1995, Journal of chemotherapy (Florence, Italy),
P Adhikari, and B M Hegde, and P Pereira, and P Bhat, and N Chowta, and K V Ramesh, and T V Venkatadri, and M M Pai
June 1996, The Journal of antimicrobial chemotherapy,
P Adhikari, and B M Hegde, and P Pereira, and P Bhat, and N Chowta, and K V Ramesh, and T V Venkatadri, and M M Pai
September 1991, The American journal of medicine,
P Adhikari, and B M Hegde, and P Pereira, and P Bhat, and N Chowta, and K V Ramesh, and T V Venkatadri, and M M Pai
March 2015, The Cochrane database of systematic reviews,
P Adhikari, and B M Hegde, and P Pereira, and P Bhat, and N Chowta, and K V Ramesh, and T V Venkatadri, and M M Pai
January 2008, The Cochrane database of systematic reviews,
P Adhikari, and B M Hegde, and P Pereira, and P Bhat, and N Chowta, and K V Ramesh, and T V Venkatadri, and M M Pai
October 2004, The Cochrane database of systematic reviews,
Copied contents to your clipboard!